Financial Services Capital Markets & Investment Management Private Equity

Leveraged Buyouts

High-stakes financial decisions requiring trust, structured diligence, and coordinated stakeholders.

Example organizations in this space: KKR Blackstone Apollo Thoma Bravo

This interactive experience is the shipped product itself — the same application code customers run in production, mounted read-only in your browser over a real sample journey. Not a video, not a mockup: because the demo and the product are one codebase, it can never drift from the real thing.

Inside this journey
  1. Pre-Sales

    Qualify and align transaction fit before investing in full diligence.

    1. Deal Qualification

      Confirm transaction size, timeline, confidentiality needs, authority, and initial financing assumptions before investing in full diligence.

      Qualification Questions

      Transaction size and control

      • What is the approximate enterprise value range you expect for this transaction? Options: Under $100M (below platform range), $100M–$499M (below target range), $500M–$1B (within target range), $1B–$5B (within target range), $5B–$10B (within target range), Over $10B (above platform range)
      • Will this be a sale of controlling ownership or a minority/other structure? Options: Sale of controlling interest (>=50%), Majority sale but <100%, Minority investment (<50%), Undecided / open to structure

      Confidentiality and timeline

      • How confidential should outreach and marketing be at this stage? Options: Public process, Confidential with standard mutual NDA, Highly confidential — very limited distribution with staged NDA, Transaction already public
      • What is your target timeline for signing a definitive agreement or closing? Options: Under 3 months, 3–6 months, 6–12 months, 12+ months, No firm target / flexible

      Decision authority and stakeholders

      • Who has final authority to approve a sale and who else must be consulted?
      • Is the ultimate decision-maker available to engage within the proposed timeline and to authorize exclusivity or an LOI if appropriate? Options: Yes — available and enabled to decide, Available but requires committee or board sign-off, Not available within requested timeline, Unsure / needs scheduling

      Financing assumptions and closing readiness

      • What initial financing structure do you expect or require from a buyer (cash at close, debt financing, seller rollover, earnout, etc.)? Options: Buyer provides fully committed cash/financing at close, Buyer financing expected with seller equity rollover, Seller financing or earnout required, Flexible / open to options
      • Are there material legal, regulatory, or third-party consents likely to affect timing or the ability to close? Options: No material consents expected, Regulatory approval required, Third-party consents required (customers/partners/landlords), Unsure — needs review
    2. Seller Outcome Discovery

      Map the seller's priorities—price, certainty, employee treatment, timeline, and board/management decision process—so the transaction is aligned to those outcomes.

      Discovery Questions

      Quick context and one-line summary

      • Tell me briefly who is leading the sale on your side and how decisions are being coordinated today
      • Describe three outcomes your team would celebrate if this transaction closed exactly as you hope
      • Which of these is nonnegotiable for you: price, timeline, employee treatment, regulatory certainty, or board unanimity Options: Price, Timeline, Employee treatment, Regulatory certainty, Board unanimity
      • Estimate your target timeline to close from signed LOI to funding, in months Options: 0-3 months, 3-6 months, 6-9 months, 9-12 months, Longer than 12 months

      Outcomes that actually move the needle

      • If you had to pick one seller outcome that would make you walk away, which is it and why
      • Rank your top three priorities from the list, with one being most critical Options: Price, Certainty of close, Employee continuity, Speed of close, Regulatory simplicity, Management future role
      • Explain a recent situation where your priorities shifted during a deal, and what triggered that change
      • Select how flexible you are on price in exchange for greater certainty from the buyer Options: Not flexible, Slightly flexible, Moderately flexible, Highly flexible
      • How would failing to achieve your top stated outcome affect the board or founder willingness to proceed Options: Stop process, Renegotiate terms, Accept with conditions, Proceed regardless

      Price versus certainty, the real trade-offs

      • How much lower in headline price would you accept in exchange for firm financing and a guaranteed close date Options: No discount acceptable, Up to 5% lower, 5-10% lower, 10-20% lower, More than 20% lower
      • Tell me what earnest money or up-front commitment would meaningfully change your confidence in a buyer Options: None, Small deposit under 1% of purchase price, 1-3% deposit, 3% or above deposit, Letter of credit or escrow
      • List the deal constructs you have used before to bridge price and certainty, for example holdbacks, escrows, or contingent consideration Options: Up-front cash with holdback, Price adjustment mechanisms, Earnout on performance, Indemnity escrows, Other
      • Would a buyer-funded insurance product for a specific closing condition make you accept a lower headline price Options: Yes, Maybe, No
      • If a buyer guaranteed closing within your timeline, what remaining risk would still prevent you from signing immediately

      People, promises, and day-one reality

      • Who among your senior managers must stay for you to feel the deal is successful, and who could leave without significant harm
      • Describe specific commitments you expect the buyer to make about employee treatment, severance, or pension plans
      • Select which retention tools you prefer for key staff Options: Equity roll or rollover, Time-based retention bonuses, New long-term incentive plan, Employment contracts, None
      • Rate the importance of public messaging to your employees in the first 30 days after close Options: Critical, Important, Somewhat important, Not important
      • Explain the single personnel risk that, if unresolved, would stop this deal

      Timeline realities, not aspirations

      • Name the timing failure in a past transaction that would make you insist on a longer close window this time
      • Estimate which regulatory or third-party approvals are most likely to delay your close Options: Antitrust/competition, Industry regulator, Customer consents, Creditor consents, Other
      • List the internal committee or board approval windows that cannot be moved
      • Share your fallback plan if financing falls through late and rate its viability Options: Well defined and viable, Partial fallback, needs work, No viable fallback
      • Would missing your target close date by more than 60 days cause you to terminate talks Options: Yes, terminate, Renegotiate timeline and terms, Accept delay if compensated, Unsure

      Boardroom dynamics and decision triggers

      • Outline how the board and major shareholders weigh price against continuity for management
      • Identify the decision makers who must sign off and the typical order they act in
      • Choose which of these would create a board veto, select one Options: Material employee layoffs, Change to executive pay, Significant carve-outs, Regulatory risk, Other
      • Share an example of a recent sale the board approved quickly and why it moved fast
      • Could a requirement for pre-closing employee agreements or extended transition commitments make you walk away Options: Yes, No, Depends on terms

      What keeps you up at night, near-term risks

      • Identify the single near-term risk that, if it materializes in the next 90 days, would end the process Options: Financing failure, Regulatory denial, Key customer loss, Management exit, Material litigation
      • Rate how likely each of these risks is for your situation Options: Highly likely, Somewhat likely, Unlikely, Unknown
      • Outline the mitigations you currently have for the top two risks
      • Could an unresolved material customer consent block be sufficient to make you walk away Options: Yes, No, Only if combined with other issues

      Operational scope, carve-outs, and must-have inclusions

      • Which specific business lines, assets, or contracts must be included for the offer to be acceptable to you
      • Name which customer contracts contain change-of-control clauses that could delay or block closing
      • Provide the percentage of revenue at risk if certain contracts or assets are excluded, using last fiscal year as the base
      • Is excluding a manufacturing site, intellectual property, or a minority JV a deal breaker for you Options: Yes, No, Depends on price and terms
      • Quantify how much your valuation expectation would shift if major carve-outs were required Options: No change, Decrease <5%, Decrease 5-10%, Decrease 10-20%, Decrease >20%

      Other paths you are actively weighing

      • Who else could you sell to or what alternate path would change your willingness to proceed with an external buyer
      • Choose which strategic alternatives you are currently evaluating Options: Single buyer direct sale, Auction managed by advisor, Recapitalization with minority partner, Internal carve-out and keep, Dividend recapitalization, Other
      • Clarify what would have to be true about your current approach for you to stay with it rather than change to an outside buyer
      • Choose whether anyone internally has proposed solving this without an outside buyer Options: Yes, CEO or founder, Yes, CFO or corp dev, Yes, operating leadership, No, Unsure
      • Does preserving timeline and price internally remove urgency to complete a sale now Options: Yes, stop sale process, No, still pursue sale, Maybe, need further analysis

      Can you execute the plan, gating conditions and constraints

      • Are there gating approvals, system dependencies, or contractual consents that would prevent a buyer from executing the plan
      • Pick the systems the buyer will need access to during diligence and integration Options: ERP / financial system, CRM and sales data, HR and payroll, Supply chain or WMS, Billing and payments, Proprietary production control, Other
      • Provide the contact role that owns access to each critical system and whether credentials or API access can be granted within 30 days
      • Assess the cleanliness and accessibility of your financial and customer data for carve-out modeling Options: Clean and accessible, Mostly clean but needs work, Fragmented and needs significant effort, Unknown
      • Is securing necessary regulatory approvals or third-party consents realistic within your target timeline Options: Yes, No, Only with additional resources
      • Does failing to meet these constraints at diligence start justify pausing or exiting the process Options: Yes, pause or exit, Renegotiate timeline and proceed, Proceed and address during integration

      Decision triggers and next steps

      • State the single condition that would make you sign an LOI within 7 days of receiving a final commercial term sheet
      • Pick the top internal approvals required and their typical lead times Options: Board approval - typical lead time, Shareholder consent - typical lead time, Major creditor sign-off - typical lead time, Regulatory filings - typical lead time, Employee consultation - typical lead time, Other
      • Predict who will be the day-one named owners and whether they are willing to be listed in closing documents Options: Founder(s), Holding company, New investor entity, Combination, Undecided
      • Will a working capital true-up and a 90-day holdback remove your need for an escrow longer than 6 months Options: Yes, No, Depends on size of holdback
      • Indicate how soon you want the buyer to present a tailored execution plan after initial terms are agreed Options: Within 1 week, Within 2 weeks, Within 4 weeks, Longer than 4 weeks, Unsure
  2. Buyer Value Plan & Terms

    Walk through the buyer's acquisition thesis, proposed financing structure, management incentives, and transition plan anchored to the seller's context.

    Solution Experience

    • Buyer Value Plan & Terms Workshop
    • Confirm the current state and its cost
    • You confirm the presented buyer thesis and business plan align to the outcomes you prioritize.
    • Provide your prioritized seller outcomes and the board's decision timeline and approval criteria before the follow-up session.
    • You confirm the financing structure provides sufficient certainty on timing and purchase price to meet your board decision criteria.
    • Walk through the buyer's acquisition thesis
    • Deliver a list of key employees and any known retention sensitivities to include in the incentives mapping.
    • Produce an initial term sheet draft and a one-page summary of financing sources and conditions reflecting the changes discussed in the meeting.
    • You confirm the proposed management incentives and transition milestones meet your minimum requirements for employee treatment and day-one readiness.
    • Review the proposed financing structure and timing
    • Validate management incentives and employee treatment
    • You identify outstanding evidence and named owners required to move to exclusivity or a mutual commit.
    • Agree on the named owners and deadlines for the remaining evidence items required for a mutual commit.
    • Walk through the transition plan and named owners
    • Forced validation, confirm alignment
    • Buyer Value Plan & Terms Workshop
    • Buyer Value Plan Deck
    • Buyer Value Plan Brief
    • meeting
    • slides
    • document
  3. Transaction Scope

    Define included assets, carve-outs, employee and management treatment, transitional services, timelines, and measurable verification criteria.

    Scope Configuration

    • Provide closing equity capital
    • Syndicate and secure senior debt financing
    • Arrange mezzanine and subordinated financing
    • Manage regulatory and antitrust filings
    • Execute 100‑day operational improvement program
    • Implement cost reduction and procurement rationalization
    • Drive revenue growth and commercial acceleration initiatives
    • Source, negotiate, and close add‑on acquisitions
    • Integrate acquired add‑ons and consolidate operations
    • Recruit and place senior management and board members
    • Implement management equity and incentive plans
    • Migrate financials and reporting to target ERP
    • Centralize treasury, cash management, and working capital

    Scope Questions

    Provide closing equity capital

    • How much equity capital (USD) are you committing to close, and is any portion subject to escrow, holdback, or earnout mechanics?
    • Which closing deliverables will you provide for equity funding (signed subscription agreement, wire confirmation, investor closing certificates)? Options: Signed subscription agreement, Cleared wire confirmation, Investor closing certificates, Escrow instructions, Other
    • Do you expect any staged draws or capital calls after signing; if yes, indicate tranche sizes and trigger events (operational milestone, regulatory clearance, financing ratification)? Options: Yes, No
    • Explain any escrow, indemnity, or purchase price holdback mechanics you require for the equity leg and the release conditions tied to the closing balance sheet or indemnity claims.
    • Provide the target date for equity funding to be fully available (wireable) relative to the targeted closing date. Options: On closing date, 1-7 days before closing, 8-30 days before closing, Other

    Syndicate and secure senior debt financing

    • Specify the preferred senior financing structure (unitranche, revolving facility plus term loan, separate senior tranches) and the lender categories you want in the syndicate (banks, institutional credit funds). Options: Unitranche, Revolver + Term Loan, Multiple senior tranches, Other
    • Which leverage multiple or maximum net debt/EBITDA must lenders accept, and state the EBITDA definition to be used for leverage (trailing twelve months, pro forma, adjusted). Options: <3.0x, 3.0-4.0x, 4.0-5.0x, >5.0x
    • Identify required covenant thresholds you will accept (minimum liquidity, interest coverage ratio, springing debt incurrence covenants) and any covenant holiday requests.
    • Confirm the evidence you will require from lenders to consider senior debt 'in scope' for closing (signed commitment letters, satisfactory diligence binder, syndication timetable). Options: Signed commitment letters, Term sheets only, Syndication timetable, Other
    • When must binding lender syndication be completed relative to the targeted closing date (number of days before close)? Options: On closing date, 7 days before, 14-30 days before, More than 30 days before

    Arrange mezzanine and subordinated financing

    • Do you expect subordinated or mezzanine capital in the stack; if yes, indicate target sizing (USD or % of equity) and expected interest mechanics (cash coupon, payment-in-kind). Options: Yes, No
    • List investor preferences you are willing to accept for subordinated capital (warrants, conversion rights, PIK interest, maturity range). Options: Warrants, Conversion features, PIK interest, Fixed cash coupon, Other
    • Specify any intercreditor or repayment priority terms that must be negotiated between senior and subordinated lenders (payment blocks, subordination periods).
    • Who on your team will lead negotiations with mezzanine providers and who will supply the investor diligence package (financial model, projections, management presentation)?
    • Provide your internal target for final pricing or yield expectation for subordinated debt and the acceptable range for negotiation.

    Manage regulatory and antitrust filings

    • List jurisdictions that will require merger notifications or filings for this transaction (for example Hart-Scott-Rodino in the U.S., Competition and Markets Authority in the U.K., EU Commission) and any local thresholds that apply.
    • Identify the specific filing deliverables we must prepare for each jurisdiction (transaction notice, market share exhibits, customer lists, commercial contracts) and who will provide them.
    • How will you manage regulatory timing and remedies, including any divestiture windows or hold-separate obligations, relative to the target closing date?
    • Indicate the lead evidence that will satisfy antitrust or regulatory clearance acceptance (regulator letter of no objection, signed settlement terms) and the expected clearance timeline. Options: Regulator letter of no objection, Approved remedies and settlement, Conditional clearance with monitoring, Other

    Execute 100‑day operational improvement program

    • Outline the 100‑day milestones you expect (stabilize cash flow, implement quick cost saves, appoint functional leads) and provide target completion dates for each milestone.
    • Select the priority operational KPIs to track in the first 100 days (EBITDA improvement USD, working capital days reduction, production uptime %) and state reporting frequency. Options: EBITDA improvement (USD), Working capital days reduction, Production uptime (%), Order fill rate, Other
    • Who are the functional owners you will assign for each 100‑day workstream (operations, supply chain, commercial, finance) and what decision authority will they have?
    • Describe the specific data feeds we will need to monitor these KPIs (ERP general ledger, shop‑floor SCADA logs, order‑to‑cash aging reports) and any access constraints.
    • State a measurable cost‑saving target for the 100‑day program (USD amount or % of cost base) and the mechanism you will use to validate realized savings.

    Implement cost reduction and procurement rationalization

    • Are there existing procurement contracts, supplier master lists, or preferred‑vendor agreements we must rationalize, and how many active suppliers are on the master list? Options: Yes, No
    • Name the top five spend categories by annual USD value and state the current source of truth for each category (accounts payable ledger, procurement system, spreadsheets).
    • Indicate supplier change constraints that impact rationalization (contract notice periods, termination fees, long‑lead supply items, single‑source components).
    • Describe required transition activities for critical suppliers (SLAs to preserve, transfer of tooling, qualification runs) and any regulatory or local content constraints.
    • Define expected governance for procurement decisions during the transition (approval thresholds, change order process, stakeholder sign‑off list).

    Drive revenue growth and commercial acceleration initiatives

    • Name the priority commercial levers you want to deploy first (pricing optimization, channel expansion, key account growth) and attach any uplift assumptions you currently model.
    • Explain how you will measure salesforce effectiveness (quota attainment, pipeline coverage ratio, sales cycle days) and which CRM reports will be the authoritative source.
    • Attach a list of the top 10 customers by revenue and indicate whether any of their contracts contain material change‑of‑control or assignment restrictions.
    • State target commercial KPIs for months 1–12 post‑close (net revenue retention %, new logo growth, average contract value) and preferred reporting cadence. Options: Monthly, Quarterly, Bi‑monthly, Other
    • Outline preferred sales compensation changes and timing (commission plan updates, retention bonuses for top performers) and the target implementation date.

    Source, negotiate, and close add‑on acquisitions

    • Define your add‑on screen for deal size and margin (revenue range, EBITDA margin, target geographies) that will trigger a buy‑and‑build pursuit.
    • Assign who will lead commercial and legal diligence on add‑on targets and which integration playbooks should be pre‑selected (systems first, product consolidation, go‑to‑market alignment).
    • Set the approval gates and return hurdles for pursuing an add‑on (minimum IRR, multiple on invested capital, strategic fit criteria).
    • Attach the list of required diligence deliverables you expect from targets (signed customer contracts, cap table, environmental reports, employee rosters) and target delivery dates.
    • When do you expect integration funding and any earnout structures to be finalized relative to deal close (pre‑close, at close, within 90 days post‑close)? Options: Pre‑close, At close, Within 30 days post‑close, Within 90 days post‑close

    Integrate acquired add‑ons and consolidate operations

    • Map integration milestones (systems rationalization, SKU consolidation, supplier harmonization) and provide expected synergy delivery timing (month 6, month 12).
    • Prioritize which ERP modules must be consolidated first (general ledger, procurement, inventory) and call out any chart‑of‑accounts mapping constraints. Options: General ledger, Procurement, Inventory, Fixed assets, Other
    • Assign who will own post‑close integration for technology and for operations and provide their escalation contacts.
    • Detail target reconciliation thresholds and migration coverage metrics for integration (for example % of invoices migrated, AR ageing coverage) that you expect as program targets.
    • Are there legacy systems or custom integrations (on‑prem ETL, bespoke manufacturing execution systems) that require long‑lead migration efforts? Options: Yes, No

    Recruit and place senior management and board members

    • Prioritize the executive roles to fill at close (CEO, CFO, COO) and indicate which roles require new employment agreements on day 1. Options: CEO, CFO, COO, Head of Sales, Head of Operations, Other
    • Select compensation benchmarks and peer groups we should use to set base salary and long‑term incentive levels.
    • Detail desired board composition (number of independents, required industry expertise, observer rights) and the timing for appointing directors.
    • Disclose any existing employment contracts that include change‑of‑control provisions, long‑term bonus obligations, or pension liabilities that could impact post‑close obligations. Options: Yes, No
    • By when do you expect to finalize CEO and CFO hire decisions relative to closing (pre‑close appointment, within 30 days post‑close, other)? Options: Pre‑close, Within 30 days post‑close, Within 60 days post‑close, Other

    Implement management equity and incentive plans

    • Propose the target management equity pool size (percent of post‑close equity) and describe planned vesting schedules (cliff, graded, performance‑based).
    • Clarify the intended tax treatment and assumed deductibility for management awards (incentive stock options, nonqualified options, restricted stock) and any required gross‑ups.
    • Designate who will administer the equity plan and maintain the cap table post‑close (internal payroll/HR, third‑party cap table provider). Options: Internal payroll/HR, Third‑party cap table provider, Law firm, Other
    • Disclose whether there are pre‑existing option pools, legacy equity holders, or outstanding warrants that require notice or consent as part of the closing deliverables. Options: Yes, No
    • Determine performance metrics tied to incentive payouts (EBITDA threshold, revenue growth, customer retention) and the measurement period for vesting or payout.

    Migrate financials and reporting to target ERP

    • Declare which source systems hold the financial close data we must migrate (legacy GL, regional ERPs, spreadsheets) and the primary owners of those systems.
    • Submit the target chart‑of‑accounts mapping rules and any mandated account reclassifications that must be applied at go‑live.
    • Confirm migration acceptance criteria for ERP cutover (for example trial balance reconciles to closing balance sheet within a specified tolerance and AR/AP migration coverage) and the reconciliation deliverables that must be produced.
    • Estimate the expected parallel‑run period for financial close and list the deliverables that mark successful cutover (subsidiary trial balance sign‑off, payroll validation, AR aging match). Options: No parallel run, 1 week, 2-4 weeks, More than 4 weeks
    • Enumerate which reconciliation reports must be delivered on day 1 post‑go‑live (closing trial balance, intercompany eliminations, fixed asset schedules).

    Centralize treasury, cash management, and working capital

    • Declare which bank accounts and legal entities should be centralized at close and provide current signatory lists that must be updated.
  4. Mutual Commit

    Finalize commercial and legal terms, exclusivity, financing commitments, and conditions precedent required to move to closing.

    Agreement Modules

    • Acquisition Agreement (Asset or Stock Purchase)
    • Disclosure Schedules
    • Equity Commitment Letter
    • Senior Debt Commitment Letter
    • Mezzanine/Subordinated Debt Commitment (if applicable)
    • Intercreditor Agreement
    • Security and Pledge Documents
    • Escrow Agreement and Escrow Instructions
    • Exclusivity and Break Fee Agreement
    • Conditions Precedent Checklist and Closing Deliverables
    • Transition Services Agreement (TSA) (conditional)
    • Management Equity Rollover and Incentive Plan
    • Employment and Retention Agreements (Key Personnel)
    • Tax Matters Agreement
    • Regulatory Approvals and Industry Compliance Addendum (conditional)
  5. Closing & Integration

    Operationalize closing with readiness checks, execution, and acceptance gates.

    1. Pre-Closing Readiness

      Confirm concrete readiness facts—financing locks, regulatory filings, consents, escrow arrangements, and named owners—to meet closing conditions.

      Pre-Closing Questions

      Closing environment and access

      • Has an escrow agent been appointed and is an escrow agreement executed? Options: Yes — escrow agreement fully executed, Yes — escrow agent appointed, agreement pending signature, No — escrow agent not yet appointed
      • Is the e-signature environment and closing document repository prepared for final execution (e.g., organization/folder created and access path assigned)? Please answer status only — we will collect exact locations in DeploymentConfig. Options: Ready for signature (access assigned), In setup — owner named but access pending, Not set up
      • Who is the named owner responsible for coordinating final signatures and document distribution? (Name and role — so we have a single day-of contact.)

      Financing and funding

      • Are the buyer's financing commitments (senior debt / mezzanine / equity) executed and unconditional for closing? Options: All commitments fully executed and unconditional, Commitments executed but subject to standard funding conditions, Commitments signed but material lender conditions remain, Financing commitments not yet executed
      • Have all funding sources and the intended beneficiary for each tranche (wire/escrow beneficiary) been confirmed for closing? (We are collecting readiness, not bank details.) Options: All funding sources named and beneficiary confirmed, Some funding sources pending confirmation, No — funding sources not finalized
      • If a funding lock date is agreed, what is the funding lock date? If unknown, enter 'TBD' — we use this to schedule wire/escrow timing.

      Regulatory filings and third-party consents

      • Which of the following regulatory approvals or third-party consents are required for closing? (Select all that apply.) Options: Antitrust/competition clearance, Industry-specific regulator approval (e.g., healthcare, telecom), Foreign investment / national security review, Key customer/contract assignment consents, Landlord/real-estate consents, Licenses or permits transfer consent, No third-party consents required, Other
      • For required filings/consents, what is the current collective status? Options: All required filings/consents obtained and unconditional, Filed — pending decision/clearance, Not filed — filings planned, Not required
      • Who is the named owner responsible for tracking outstanding filings/consents and providing clearance confirmation? (Name and role — we will follow up for expected clearance dates.)

      People, signature authority, and timing constraints

      • Is the closing signature list finalized with named signatories and specimen names on file where required? Options: Yes — signatory list finalized and specimens on file, Yes — list finalized, specimens pending, No — signatory list not finalized
      • Who are the primary day-of owners for the buyer and the seller (name and role) authorized to resolve closing issues and approve minor adjustments?
      • Are there any blackout windows, site-level operational constraints, or legal/regulatory restrictions that would prevent closing on a target date? (If yes, we will capture exact windows in DeploymentConfig.) Options: No known constraints, Yes — operational/site blackout(s) exist, Yes — regulatory hold expected, Unsure
    2. Closing Deliverables

      Capture the exact closing items the closing team will use—final agreements, wire/escrow instructions, signature lists, and certificate/transfers details.

      Closing Deliverables

      Closing Deliverables — Core Identifiers

      • Final binding purchase agreement document identifier (format: secure-file-path or document-management ID). This value is consumed by the closing module to fetch the signed agreement. Do NOT paste confidential account or key material.
      • Ancillary agreements package identifier (format: secure-file-path, DMS folder ID, or document bundle ID). Enter 'NONE' if there are no ancillary agreements to include. Consumed by contract packaging at closing.
      • Final executed signature register identifier (name of the signature-list file or document ID used to verify executed signatures). Consumed by the signature-tracking step.

      Financial Settlement & Escrow

      • Primary funding destination type (select one). This configures which payment validation workflow the closing engine runs. Options: Buyer bank account (on-balance), Third-party escrow agent account, Special-purpose vehicle (SPV) account, Other
      • Wire/escrow instruction document identifier (format: secure-file-path or DMS ID). Do NOT paste bank account numbers or routing details here — provide the identifier only. The actual account details will be exchanged via your secrets manager at kickoff.
      • Owner of the payment credential (enter the role or team responsible for providing the confidential wiring details via your secrets manager — e.g., 'buyer-treasury', 'escrow-ops'). Used to route the secret exchange.

      Signatures & Verification

      • Signature execution method (select one). This determines the signature routing and evidence collection workflow. Options: Wet-ink only, Electronic signature permitted, Hybrid (mix of wet-ink and e-sign)
      • Signing authority owner (role/team who will maintain and finalize the signatory roster — e.g., 'seller-corporate-secretary', 'buyer-legal'). The closing module will query this owner for final signer confirmations.

      Certificates, Transfers & Handover

      • Stock/asset transfer certificate identifier or transfer-document ID (format: secure-file-path or DMS ID). Enter 'NONE' if no certificate issuance or transfer document applies. Consumed by the transfer execution workflow.
      • Registrar / transfer-agent type (select one). Determines the transfer execution path and required handoffs. Options: Internal transfer agent (in-house), Third-party transfer agent, No transfer agent / direct issuance

      Closing Verification & Post-Close Handover

      • Final closing condition checklist identifier (format: secure-file-path or checklist ID). This single checklist is consumed verbatim by the platform's closing verifier to mark conditions satisfied.
      • Post-closing named owners list identifier for operational handover (format: secure-file-path or DMS ID). Default filename suggestion: 'post-close-owners.xlsx' — change if you already have a different file. Consumed by the handover and integration endpoint.
    3. Closing & Funding

      Execute the closing sequence: satisfy conditions, fund sources, effect transfers of control, and complete operational handover with named owners.

    4. Regulatory & Acceptance Sign-Off

      Verify regulator approvals, financing conditions, and contractual acceptance items are satisfied before declaring the transaction closed.

      Checklist items

      • Receive written clearance from competition/regulatory authorities required for closing
      • Obtain governmental filing receipts and official acceptance confirmations required by closing conditions
      • Obtain executed consents or waivers from material third-party counterparties listed in the conditions schedule
      • Confirm lenders' final funding notices and formal satisfaction of financing conditions
      • Collect fully executed financing agreements and security/perfection documents required at closing
      • Confirm escrow account established and required funds deposited per escrow instructions
      • Obtain certified corporate approvals and officer certificates from buyer and seller as required by the purchase agreement
      • Receive fully executed closing deliverables listed in the transaction schedules (purchase agreement, ancillary agreements, exhibits)
      • Obtain required tax authority clearances or written tax no-objection certificates
      • Obtain signed final closing statement and closing-agent acceptance certificate confirming all conditions precedent satisfied
  6. Value Realization & Integration

    Track integration milestones, value-creation initiatives, management performance, and maintain a shared channel for issues and post-close adjustments.

    Success Reviews

    • Go-live Health Check (weeks 1-4)
    • First Measurement Review (weeks 4-10)
    • 90-Day Integration Checkpoint (around day 90)
    • Quarterly Value Realization Review

    Issues & Enhancements

    • Provide an updated list of upcoming add-on integration milestones and their expected completion windows.
    • Integration milestone status
    • Document percent-complete for core integration milestones and a dated plan to reach 100 percent where gaps exist.
    • Confirm incumbent system is either decommissioned or formally retained read-only with data archived, and that renewal obligations are closed or reassigned.
    • Agree a remediation schedule that will materially move run-rate cost savings toward the targets recorded in Buyer Value Plan & Terms.
    • Produce a milestone completion register showing percent complete, outstanding tasks, and owners for each milestone.
    • If incumbent is retained read-only, publish the retention terms, archive confirmation, and fallback procedure documentation.
    • Schedule executive escalation for any unresolved critical issues that cannot be closed within 30 days.
    • KPI trend review
    • Confirm KPI direction for EBITDA margin improvement and add-on integration milestone completion rate and note any deviations requiring escalation.
    • Reduce the critical issue backlog by at least one agreed priority cluster before the next quarterly review.
    • Agree a short list of measurable commitments and reporting templates for the next quarter.
    • Deliver the quarterly KPI pack showing variance to targets recorded in Buyer Value Plan & Terms and drill-downs for each major variance.
    • Publish a prioritized issue burn-down plan with dates and outcomes expected for the next quarter.
    • Re-confirm success criteria and ownership
    • Confirm that critical systems and data required for operations are live and reconciled.
    • List top 3 blockers with owners and resolution dates to be resolved before the first measurement review.
    • Establish a single shared issue tracker and escalation path for all post-close items.
    • Publish reconciled migration validation report and attach logs to the shared issue tracker.
    • Record named owners and due dates for the top 3 blockers in the shared issue tracker.
    • Enable access to the agreed integration channel for all named stakeholders.
    • Present first-period results against targets
    • Document delta between actual EBITDA run-rate and the target recorded in Buyer Value Plan & Terms, with a remediation plan and dates.
    • Confirm the management retention status and list any at-risk roles with mitigation steps.
    • Create a clear ownership plan for each corrective action with dates for the next status update.
    • Deliver a reconciled month-to-date P&L that isolates the drivers of EBITDA variance and post to the shared folder.
    • Publish a retention mitigation plan for at-risk management roles with proposed incentives and timeline.
    • Add any new defects or process gaps to the shared issue tracker and set priority levels.
    • Deployment and data migration validation
    • Management performance and incentive milestones
    • Root-cause diagnosis for gaps
    • Run-rate cost savings realized
    • Agree corrective actions with milestones
    • Incumbent system wind-down status
    • Persistent issue burn-down
    • Early adoption signals
    • Update integration issues backlog
    • Open blockers and immediate risks
    • Outstanding critical issues and escalations
    • Confirm next quarter commitments and reporting cadence
    • Agree 30/60/90 day remediation milestones
    • Agree remediation actions and short-term cadence
First-Party AI

1-2 minutes please — Your AI agent is working

First-Party AI™ can make mistakes. Always check important information.